Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Doctors vary in how they initially test for PCOS, but most agree on using oral contraceptives and lifestyle changes as first treatments.

Androgen levels do not determine the type of PCOS symptoms in young females.

Teens with PCOS have a higher risk of type 2 diabetes and need regular glucose checks.

Older men with lower levels of available testosterone are more likely to be frail.

Melatonin protects skin and hair from damage and stress by acting as an antioxidant and influencing cell growth.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Some treatments work better for different types of hair loss, and nutrients like iron and L-lysine are important for preventing hair loss.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Alopecia patients have less GPER-1, which might affect hair loss.

Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.

Endocrine disruptors may cause early hair loss.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.